Stocktoria
Perspective Therapeutics, Inc. CATX
NYSE American · XASE · stock · Pharmaceutical Preparations · website · IPO 2002-05-31
Perspective Therapeutics, Inc. statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 100.0% | — | 0.0% | 50.9% | 52.9% | 41.7% | 31.1% | 17.6% |
| Operating margin | — | — | -2855.0% | — | -59.5% | -34.3% | -35.9% | -71.8% | -113.6% | -132.5% |
| Net margin | — | — | -3243.2% | — | -67.4% | -33.7% | -35.6% | -70.3% | -113.1% | -129.4% |
| FCF margin | — | — | -2648.9% | — | -73.9% | -32.0% | -40.4% | -75.1% | -102.1% | -131.5% |
| Return on assets | -38.6% | -23.2% | -47.5% | -18.5% | -11.3% | -4.8% | -39.6% | -54.6% | -89.9% | -50.2% |
| Return on equity | -49.8% | -27.3% | -61.9% | -19.7% | -11.9% | -5.0% | -60.2% | -67.0% | -133.2% | -58.1% |
| Debt / equity | 0.01× | 0.01× | 0.02× | — | — | — | — | — | — | — |
| Current ratio | 5.17 | 12.68 | 1.07 | 17.07 | 26.18 | 37.37 | 3.50 | 6.53 | 2.97 | 9.30 |
Source: SEC EDGAR filings · CIK 0000728387 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.